The Dow Chemical Company has formed a new independent company that will be known as Pfenex Inc. through its Dow Venture Capital group. The new company, headquartered in San Diego, CA, is based on human health applications of a Dow-developed technology called Pfēnex Expression Technology. The action is consistent with Dow’s strategy of active portfolio management, according to a company statement. Dow will hold a significant minority stake in Pfenex along with Signet Healthcare Partners, a ven...